Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Clinical trial NCT00089219 · COMPLETED

Trial details

NCT number: NCT00089219
Sponsor: University of Virginia
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 2003-07-01
Primary completion: 2006-05-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.